|
KDM1A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.788300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.823600E-02 |
| Normal-vs-Stage2 |
4.478300E-03 |
| Normal-vs-Stage3 |
1.177610E-01 |
| Normal-vs-Stage4 |
5.360000E-02 |
| Stage1-vs-Stage2 |
9.920000E-02 |
| Stage1-vs-Stage3 |
5.582800E-01 |
| Stage1-vs-Stage4 |
5.772200E-01 |
| Stage2-vs-Stage3 |
3.805800E-01 |
| Stage2-vs-Stage4 |
4.908000E-01 |
| Stage3-vs-Stage4 |
8.936400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.919900E-02 |
| Normal-vs-AfricanAmerican |
2.236300E-02 |
| Normal-vs-Asian |
9.519000E-01 |
| Caucasian-vs-AfricanAmerican |
3.560200E-01 |
| Caucasian-vs-Asian |
6.231200E-01 |
| AfricanAmerican-vs-Asian |
2.947200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.464900E-03 |
| Normal-vs-Female |
9.811200E-01 |
| Male-vs-Female |
2.542100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.085640E-01 |
| Normal-vs-Extreme_Weight |
2.031600E-02 |
| Normal-vs-Obese |
8.613500E-02 |
| Normal-vs-Extreme_Obese |
8.031700E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.286000E-01 |
| Normal_Weight-vs-Obese |
9.603400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.225000E-01 |
| Extreme_Weight-vs-Obese |
6.589600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.108000E-01 |
| Obese-vs-Extreme_Obese |
3.000600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.781200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.119000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.713800E-02 |
| Normal-vs-Age(81-100Yrs) |
1.734210E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.537150E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.052810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.367800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.883000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.281500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.576170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.496000E-01 |
| Normal-VS-Type2 PRCC |
4.64280000000983E-08 |
| Normal-VS-KIRP CIMP |
2.302800E-01 |
| Normal-VS-Unclassified PRCC |
1.176830E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.76089999645879E-08 |
| Type1 PRCC-VS-KIRP CIMP |
4.588500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.927400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.04349999999298E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
4.255700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.106100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.025100E-04 |
| Normal-vs-N1 |
3.941400E-01 |
| Normal-vs-N2 |
3.493000E-01 |
| N0-vs-N1 |
1.104970E-01 |
| N0-vs-N2 |
5.345800E-01 |
| N1-vs-N2 |
8.632600E-01 |
|
|
